CoChat

MRI assessment of whole-brain structural changes in aging

Open access

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Purpose: One of the central features of brain aging is the accumulation of multiple age-related structural changes, which occur heterogeneously in individuals and can have immediate or potential clinical consequences. Each of these deficits can coexist and interact, producing both independent and additive impacts on brain health. Many of the changes can be visualized using MRI. To collectively assess whole-brain structural changes, the MRI-based Brain Atrophy and Lesion Index (BALI) has been developed. In this study, we validate this whole-brain health assessment approach using several clinical MRI examinations. Materials and methods: Data came from three independent studies: the Alzheimer’s Disease Neuroimaging Initiative Phase II (n=950; women =47.9%; age =72.7±7.4 years); the National Alzheimer’s Coordinating Center (n=722; women =55.1%; age =72.7±9.9 years); and the Tianjin Medical University General Hospital Research database on older adults (n=170; women =60.0%; age =62.9±9.3 years). The 3.0-Tesla MRI scans were evaluated using the BALI rating scheme on the basis of T1-weighted (T1WI), T2-weighted (T2WI), T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), and T2*-weighted gradient-recalled echo (T2*GRE) images. Results: Atrophy and lesion changes were commonly seen in each MRI test. The BALI scores based on different sequences were highly correlated (Spearman r 2 >0.69; P <0.00001). They were associated with age ( r 2 >0.29; P <0.00001) and differed by cognitive status ( χ 2 >26.48, P <0.00001). T2-FLAIR revealed a greater level of periventricular ( χ 2 =29.09) and deep white matter ( χ 2 =26.65, P <0.001) lesions than others, but missed revealing certain dilated perivascular spaces that were seen in T2WI ( P <0.001). Microhemorrhages occurred in 15.3% of the sample examined and were detected using only T2*GRE. Conclusion: The T1WI- and T2WI-based BALI evaluations consistently identified the burden of aging and dementia-related decline of structural brain health. Inclusion of additional MRI tests increased lesion differentiation. Further research is to integrate MRI tests for a clinical tool to aid the diagnosis and intervention of brain aging. Keywords: aging, brain atrophy and lesion index (BALI), brain health, MRI pulse sequences, structural brain changes

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/cia.s139515

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Examples of the characteristic changes shown on T2-FLAIR in comparison with those shown on T1WI and T2WI. Notes: T2-FLAIR is comparatively more sensitive in detecting white matter lesions as shown in subcortical white matter (A), deep white matter (B), and periventricular white matter (C). Lacunar malacia in multiple regions are also seen more clearly on T2-FLAIR (D, E), shown as lower signal intensity in the central part surrounded by high signal intensity. In contrast, compared to T1WI and T2WI, the dilated perivascular spaces located in multiple sites are not seen on T2FLAIR, for example, in the subcortical region (F), and basal ganglia and surrounding region (G). Abbreviations: T1WI, T1-weighted image; T2WI, T2-weighted image; T2-FLAIR, T2-weighted fluid-attenuated inversion recovery.
Figure 1 Examples of the characteristic changes shown on T2-FLAIR in comparison with those shown on T1WI and T2WI. Notes: T2-FLAIR is comparatively more sensitive in detecting white matter lesions as shown in subcortical white matter (A), deep white matter (B), and periventricular white matter (C). Lacunar malacia in multiple regions are also seen more clearly on T2-FLAIR (D, E), shown as lower signal intensity in the central part surrounded by high signal intensity. In contrast, compared to T1WI and T2WI, the dilated perivascular spaces located in multiple sites are not seen on T2FLAIR, for example, in the subcortical region (F), and basal ganglia and surrounding region (G). Abbreviations: T1WI, T1-weighted image; T2WI, T2-weighted image; T2-FLAIR, T2-weighted fluid-attenuated inversion recovery.CC BY-NC · PubMed Central
Figure 2 Examples of the characteristic changes shown on T2*GRE in comparison with those shown on T1WI and T2WI. Notes: Changes of each BALI category are less reliably identified on T2*GRE than on T2WI or T1WI. Susceptive lesions are more sensitively revealed on T2*GRE, for example, calcification (A), microhemorrhage (B), multiple microhemorrhages (C), and malacia with hemosiderin deposition (D). Abbreviations: BALI, brain atrophy and lesion index; T1WI, T1-weighted image; T2WI, T2-weighted image; T2*GRE, T2*-weighted gradient recalled echo sequence.
Figure 2 Examples of the characteristic changes shown on T2*GRE in comparison with those shown on T1WI and T2WI. Notes: Changes of each BALI category are less reliably identified on T2*GRE than on T2WI or T1WI. Susceptive lesions are more sensitively revealed on T2*GRE, for example, calcification (A), microhemorrhage (B), multiple microhemorrhages (C), and malacia with hemosiderin deposition (D). Abbreviations: BALI, brain atrophy and lesion index; T1WI, T1-weighted image; T2WI, T2-weighted image; T2*GRE, T2*-weighted gradient recalled echo sequence.CC BY-NC · PubMed Central
Figure 3 Microhemorrhage on T2*GRE at 3.0T. Note: A score between 0 and 3 is given to grade the severity of microhemorrhage, which can range from clear to one, multiple, and diffused spots. Abbreviation: T2*GRE, T2*-weighted gradient recalled echo sequence.
Figure 3 Microhemorrhage on T2*GRE at 3.0T. Note: A score between 0 and 3 is given to grade the severity of microhemorrhage, which can range from clear to one, multiple, and diffused spots. Abbreviation: T2*GRE, T2*-weighted gradient recalled echo sequence.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 41

Metadata

Authors
Guo, H., Siu, W., D’Arcy, R., Black, S., Grajauskas, L., Singh, S., Zhang, Y., Rockwood, K., & Song, X.
Affiliations
  • Fraser Health (CA)
  • Sunnybrook Health Science Centre (CA)
  • University of British Columbia (CA)
  • Tianjin Medical University General Hospital (CN)
  • Dalhousie University (CA)
Corresponding author
Song, Xiaowei
Venue
Clinical Interventions in Aging
Published
2017-08
Volume
Volume 12
Pages
1251-1270
ISSN
  • 1176-9092 (ISSN-L)
  • 1178-1998
OpenAlex
W2744275124
Cited by
39
References
37
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 9 · 2020: 6 · 2019: 4 · 2018: 4
FWCI
3.14
Type
journal article
Language
en
Open access
Locations
  • Clinical Interventions in Aging (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • U.S. Department of Defense (U01 AG024904, W81XWH, W81XWH-12-2-, W81XWH1220012, AG024904)
  • Foundation for the National Institutes of Health (W81XWH-12-2-0012, U01AG024904, Grant U01 AG024904, AG024904)
  • Alzheimer's Association (U01 AG024904, W81XWH-12-2-0012)
  • Bristol-Myers Squibb (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Eli Lilly and Company (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Pfizer (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • Biogen (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • Meso Scale Diagnostics (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Alzheimer's Disease Neuroimaging Initiative (W81XWH-12-2–0012, U01AG024904, AG024904, W81XWH-12-2-, Department of Defense award number W81XWH-12-2-0012)
  • Dalhousie Medical Research Foundation
  • BioClinica (U01 AG024904, W81XWH-12-2-0012, AG024904)
  • Novartis Pharmaceuticals Corporation (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • Northern California Institute for Research and Education (U01 AG024904, W81XWH-12-2-0012)
  • National Alzheimer's Coordinating Center
  • National Natural Science Foundation of China (U01 AG024904, 81401379, W81XWH-12-2-0012)
  • Dalhousie University
  • Eisai (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • Servier (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • IXICO (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • National Institutes of Health (3u01ag024904-10s2, W81XWH, W81XWH-12-2-0012, U01-AG024904, Grant U01 AG024904, AG024904)
  • Genentech (W81XWH-12-2-0012, AG024904, U01 AG024904)
  • Canadian Institutes of Health Research (U01 AG024904, W81XWH-12-2-0012)
  • National Institute on Aging (U01-AG-024904, P30AG010129, P30AG010133, W81XWH-12-2–0012, P30AG028383, P30AG012300, P50AG005133, AG 024904, U01AG016976, P50AG005131, P50AG005138, P50AG016570, P30AG010124, P50AG016573, P50AG047366, P30AG008017, P30AG010161, P30AG008051, P50AG008702, P50AG033514, P30AG035982, P50AG005681, P50AG005142, P50AG047270, P30AG019610, P50AG005146, P30AG013846, P50AG005136, P50AG005134, P30AG013854, P50AG025688, P50AG047266, P50AG023501, P50AG016574)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
brain aging, brain atrophy, white matter lesions, periventricular lesions, microhemorrhages, perivascular spaces, T2-FLAIR, T1-weighted imaging, T2-weighted imaging, cognitive status, dementia, older adults
MeSH terms
Adult, Aged, Aging, Alzheimer Disease, Atrophy, Brain, Female, Humans, Magnetic Resonance Imaging, Male

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MRI assessment of whole-brain structural changes in aging. https://app.cochat.ai/papers/10.2147/cia.s139515
The paper
Guo, H., Siu, W., D’Arcy, R., Black, S., Grajauskas, L., Singh, S., Zhang, Y., Rockwood, K., & Song, X. (2017). MRI assessment of whole-brain structural changes in aging. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s139515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.